Schonfeld Strategic Advisors LLC

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1665241 NEW YORK, NY

Position in RLMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$161,799

+$97,966 QoQ

Shares Held

23,247

+75.9% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $296,187,490 across 126 Biotechnology names. RLMD ranks #84 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,757,899	$25,419,219
2	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
3	PTCT	Ptc Therapeutics, Inc.	318,405	$21,692,932
4	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
5	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
6	JAZZ	Jazz Pharmaceuticals plc	62,142	$11,747,945
7	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
8	INSM	INSMED Inc	56,056	$9,166,277

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$161,799	23,247	+75.9%	Shares	Sole	2026-05-15
2025-12-31	$63,833	13,216	-87.9%	Shares	Sole	2026-02-17
2023-09-30	$327,930	109,310	+45.2%	Shares	Sole	2023-11-14
2022-12-31	$262,797	75,300	-50.0%	Shares	Sole	2023-02-14
2022-09-30	$5,571,510	150,500	+174.6%	Shares	Sole	2022-11-14
2021-12-31	$1,234,644	54,800	-51.5%	Shares	Sole	2022-02-14
2021-09-30	$2,960,104	112,938	+95.5%	Shares	Sole	2021-11-16
2021-06-30	$1,848,929	57,761	+6.0%	Shares	Sole	2021-11-16
2021-03-31	$1,918,980	54,501	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.